ASCO 2026 GU Cancer — Influencer Networks

This visualization is compiled by the KOL Pulse research team from curated GU-cancer tweets tagged to ASCO 2026 and enriched with engagement identities via the X API. Every account is classified against the KOL Pulse registry (verified US physicians are cross-referenced with CMS Open Payments). No accounts are fabricated; all tweet counts and impressions are as reported by X.

What does the ASCO 2026 GU cancer influencer network show?

It maps the retweet, quote, and mention relationships among 1241 X/Twitter accounts discussing GU cancer research at ASCO 2026 Annual Meeting. Node size reflects impressions; ring color reflects account type (verified US physician, international MD, media/org, amplifier, or mentioned). 146 accounts authored original GU-cancer tweets.

How do I filter the network by clinical trial?

Use the GU Trial dropdown in the left control panel. Selecting a trial (for example PROTEUS, NIAGARA, KEYNOTE-564, TALAPRO-3, or IMvigor011) shows only the accounts and edges tied to that trial. An account is tied to a trial when it authored a tweet tagged to that trial or engaged a KOL who did. Choose 'All GU trials' to return to the full network.

How are US physicians verified?

Accounts classified as US physicians are cross-referenced against the CMS Open Payments dataset and the KOL Pulse classified registry. They render with a gold ring and a US badge.

Which GU trials are represented?

The filterable trials (each tied to at least three curated tweets) are PROTEUS, TALAPRO-3, LITESPARK-022, IMvigor011, KEYNOTE-B15/EV-304, EV-302/KEYNOTE-A39, POTOMAC, KEYNOTE-564, ARACOG, RAMPART, ARC-20, KEYNOTE-905/EV-303, AMBASSADOR/KEYNOTE-123, VOLGA, NEXUS-01, ENZAMET.

What is the data source?

KOL Pulse curated 549 GU-cancer tweets tagged to ASCO 2026 and enriched them with engagement identities (who retweeted and quoted each post) via the X API. Accounts were then classified using the KOL Pulse registry.